NXGL (NEXGEL, Inc) Market Value to Book Value Ratio

NEXGEL, Inc (NXGL) - corporate logo

This chart of NEXGEL, Inc. (NXGL) stock quotes on the GURU.Markets platform reflects the business dynamics of a company creating advanced hydrogel dressings for dermatology and medicine. The current indicator is 0.42. The development model relies on shop-floor automation, which reduces costs and increases profits. The priority is expansion within the transdermal drug delivery and skin wound healing segments.

NXGL - NEXGEL Inc Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026
Manufactured products of NEXGEL Inc.

This indicator compares the market value of NEXGEL, Inc. (NXGL) to its net assets, determining the extent of capital overvaluation or undervaluation. The ratio reveals the gap between exchange quotes and the real value of assets minus liabilities. By analyzing changes in the company's P/BV level, an investor can identify the fundamental bottom. Stable demand for NEXGEL, Inc. (NXGL) hydrogel patches minimizes the risk of business degradation, turning this metric into a reliable filter for valuing a high-quality asset.

Direct competitors

Intuitive Surgical (ISRG) - Market Value to Book Value Ratio|DHR (danaher.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio Utah Medical Products|Market Cap to Book Value Multiple KRMD (korumedical.com)|Market Value to Book Value Ratio Nyxoah|MBOT - Market Value to Book Value|Pro-Dex Corp - Market Cap to Net Assets Ratio|ZTEK: Market Capitalization to Book Value Ratio|ELUT (Elutia Inc.) - Market Value to Book Value Ratio|milestonescientific.com (MLSS) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value